News Headline Summary

Celgene (CELG) gets Apremilast orphan status for Behect's disease

Reaction details (18:03)

- Small move to the upside following this news, last trade at USD 99.01 (+0.15%).

17 Jan 2013 - 18:01 - Equities - Source: Hammerstone

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: